Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Conmed (CNMD) Gross Profit (2016 - 2025)

Conmed's Gross Profit history spans 16 years, with the latest figure at $218.3 million for Q4 2025.

  • For Q4 2025, Gross Profit rose 10.05% year-over-year to $218.3 million; the TTM value through Dec 2025 reached $750.5 million, up 2.38%, while the annual FY2025 figure was $750.5 million, 2.38% up from the prior year.
  • Gross Profit reached $218.3 million in Q4 2025 per CNMD's latest filing, up from $166.1 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $218.3 million in Q4 2025 to a low of $128.4 million in Q1 2021.
  • Average Gross Profit over 5 years is $165.0 million, with a median of $167.1 million recorded in 2023.
  • Peak YoY movement for Gross Profit: surged 96.62% in 2021, then dropped 15.39% in 2022.
  • A 5-year view of Gross Profit shows it stood at $155.9 million in 2021, then dropped by 15.39% to $131.9 million in 2022, then skyrocketed by 38.16% to $182.2 million in 2023, then rose by 8.88% to $198.3 million in 2024, then grew by 10.05% to $218.3 million in 2025.
  • Per Business Quant, the three most recent readings for CNMD's Gross Profit are $218.3 million (Q4 2025), $166.1 million (Q3 2025), and $188.3 million (Q2 2025).